A key finding of the ENCODE project is that the enhancer landscape of mammalian cells undergoes marked alterations during ontogeny. However, the nature and extent of these changes are unclear. As part of the NIH Mouse Regulome Project, we here combined DNaseI hypersensitivity, ChIP-seq, and ChIA-PET technologies to map the promoterenhancer interactomes of pluripotent ES cells and differentiated B lymphocytes. We confirm that enhancer usage varies widely across tissues. Unexpectedly, we find that this feature extends to broadly transcribed genes, including Myc and Pim1 cell-cycle regulators, which associate with an entirely different set of enhancers in ES and B cells. By means of high-resolution CpG methylomes, genome editing, and digital footprinting, we show that these enhancers recruit lineage-determining factors. Furthermore, we demonstrate that the turning on and off of enhancers during development correlates with promoter activity. We propose that organisms rely on a dynamic enhancer landscape to control basic cellular functions in a tissue-specific manner.
INTRODUCTION
Gene expression during development is orchestrated by promoter sequences and a variety of distal cis-regulatory elements. Key among these are enhancers, which associate with promoters to increase the transcriptional output of target genes in a tissue-specific manner (Visel et al., 2009) . Enhancers are typically distinguished from nonregulatory DNA by their hypersensitivity to DNaseI digestion (Sabo et al., 2006) and binding of chromatin modifiers. The CBP/p300 acetyltransferase for instance mediates H3K27 acetylation of chromatin at active enhancers (Creyghton et al., 2010) . In addition, enhancers display high levels of H3K4 monomethylation (H3K4me1; Buecker and Wysocka, 2012) , and a relative depletion of H3K4me3 (Heintzman et al., 2007) and the histone variant H2AZ (Kouzine et al., 2013) . Based on these parameters, $400,000 genomic sites displaying enhancer-like features were recently discovered, spanning nearly 10% of the human genome (ENCODE Project Consortium et al., 2012) .
Enhancers control lineage identity by recruiting transcription factors, cofactors, and RNA Polymerase II (PolII) to target genes. They physically interact with promoters resulting in looping out of intervening sequences (Krivega and Dean, 2012) , which in some instances can span over 1 Mb of DNA (Nobrega et al., 2003) . In contrast to promoters and insulators, which vary little across cell types, the enhancer landscape changes considerably during development . This feature predicts that functional connectivity in mammalian cells (1) must display a high degree of tissue specificity and (2) should closely reflect transcriptome changes during cell differentiation. However, these ideas have not been fully explored because of the difficulty of mapping promoter-enhancer connections during development.
In the absence of direct approaches, enhancers have been typically assigned to ''cognate'' promoters based on linear proximity or shared chromatin states. This strategy has limitations because enhancers do not always regulate nor share chromatin profiles with the nearest promoter. Alternatively, chromosome conformation capture techniques have been used to explore regulatory interactions at predefined genomic loci. However, the resolution of 3C-based techniques alone is insufficient to map promoter-enhancer connectivity in entire genomes (Xie and Ren, 2013) . To overcome this challenge, the ChIA-PET protocol was recently developed (Fullwood et al., 2009) . ChIA-PET is a ChIP-based method that captures long-range chromatin interactions involving or mediated by a protein of interest such as estrogen receptor a in adenocarcinoma cells (Fullwood et al., 2009) or RNA PolII in human cell lines .
We here introduce the NIH Mouse Regulome Project, an initiative that seeks to define the 3D interplay of gene regulatory domains in developing mouse primary cells. In this first report we compare pluripotent embryonic stem (ES) cells and differentiated B lymphocytes. By combining ChIA-PET, CpG methylomes, DNaseI hypersensitivity, transcriptomes, digital footprinting, and TALEN-mediated genome editing, our studies reveal the dynamics of the mouse regulome during ontogeny.
RESULTS

A Comprehensive Map of Regulatory Domains and Their Interactions in Mouse Primary Cells
To characterize the mouse regulome in primary cells we first applied DNaseI hypersensitivity (DHS) followed by deepsequencing to CD43 À B lymphocytes activated in the presence of lipopolysaccharide and interleukin-4 (LPS+IL-4). From two independent experiments (268 million aligned reads), we identified 90,015 high-confidence DNaseI domains in B cells. As expected, DNaseI-seq profiles were highly reproducible between biological replicates (Spearman's r = 0.99; Figure S1A available online).
To identify DHS sites associated with gene regulatory domains, we next mapped Nipbl, Med12, and p300 by ChIP-seq (Figure 1A) . We chose the cohesin-loading factor Nipbl and the Med12 component of mediator because they demarcate enhancers tethered with core promoters (Kagey et al., 2010) . Likewise, the transcription regulator p300 occupies a subset of active promoters and enhancers (Chen et al., 2008) . There was a considerable, although incomplete, overlap in the recruitment of these factors in B cells (Figures 1A and S1B Figure 1B ). Promoters were in general H3K4me1-low H3K4me3 high H2AZ high , whereas the opposite signature demarcated enhancer domains ( Figure 1A ; Kouzine et al., 2013) . DHS analysis of mouse ES cells uncovered a similar number of DHS promoters (16, 771) and an increased number of enhancers (62,766, Figure 1B ).
To directly map the promoter-enhancer interactome, we applied chromatin interaction analysis by paired-end-tag sequencing (ChIA-PET; Fullwood et al., 2009; Zhang et al., 2012) , which combines PolII ChIP with 3C technology ( Figures  1C, S2A) . We generated two independent B cell ChIA-PET libraries, from which $15 million reads were uniquely aligned and classified into two separate data sets: 5.7 million reads of PolII chromatin occupancy, and 9.2 million reads clustered into 14,247 high-confidence PolII long-range cis interactions or PETs ( Figure 1D and Table S1 ). Both data sets were correlated between replicates (Spearman's r > 0.83, Figures S2B  and S2C ).
Attesting to the specificity of ChIA-PET, most PolII long-range interactions (13,070, 92%) were linked to at least one gene regulatory domain ( Figure S1C ). Furthermore, of 16,931 B cell promoters associated with DHS domains, 6,890 were involved in PolII long-range interactions. In general, these genes were transcribed 2-fold higher (p < 2 3 10 16 , Figure S1D ) and recruited more PolII (p < 2 3 10 16 , Figure S1E ) than nonanchored ones. We also detected 6,813 DHS enhancer domains involved in PolII interactions. Of these, 71% were active (H3K27Ac + ), whereas up to 60% of nonanchored ones were poised (H3K27Ac Figure S1F) . In general, the number of ChIA-PET interactions per regulatory site was proportional to the extent of DNaseI digestion ( Figure S1G ). Thus, ChIA-PET preferentially detects PolII longrange interactions involving H3K27Ac + enhancers and transcriptionally active promoters. As previously shown , PolII interactions fell into four distinct groups: (1) intragenic, connecting promoters to gene bodies; (2) extragenic, connecting promoters to distal regulatory elements; (3) intergenic, tethering promoters from different genes; and (4) enhancer-enhancer interactions (Figure S1H) . Examples of these are provided in Figure 1D for the Atp5j-Mir155 gene locus. Consistent with high expression of Mir155 in activated B cells (Kuchen et al., 2010) , its promoter was associated with 83 long-range interaction tags (Figure 1D, upper) . Of these, 70 were extragenic, involving 5 upstream enhancer domains, while 13 were intragenic, connecting the promoter to downstream sequences. An additional 23 PolII longrange interactions interconnected the 5 enhancers upstream of Mir155. In contrast to B cells, ES cells actively transcribe Mrpl39, Jam2, and Atp5j but express little Mir155 mRNA (Figure 1D, lower) . Consistent with this, we identified 30 intergenic connections between Mrpl39, Jam2, and Atp5j promoters in ES cells, whereas few connections involved Mir155 ( Figure 1D ). As in previous ChIA-PET studies, both direct and indirect interactions were considered in our analysis ( Figure S1I ).
TALEN-Mediated Validation of Promoter-Enhancer Connectivity
ChIA-PET confirmed established connections between gene regulatory domains. For instance, the pluripotent gene Sox2 was associated in ES cells with a series of enhancers recently described by 5C studies ( Figure S3A ; Phillips-Cremins et al., 2013) . Likewise, the immunoglobulin heavy chain (Igh) 3 0 Ea enhancer was found in spatial proximity to transcribed Igm, Igg1, and Igε in B cells only ( Figure S3B ). We also found evidence of Igm-Igg1 associations, representing either synapses between the recombining genes (Wuerffel et al., 2007) E2 chr6:122,474,255-122,556,944 chr6:122,745,356-122,848,127 188,412bps E6 ( (legend continued on next page) Meyer and Neuberger, 1989) . Unexpectedly, the analysis uncovered two additional enhancers located 8 kb (E4) and 15 kb (E5) downstream of Ed ( Figure 2A ). We also found additional enhancers (E1-E2) associated with the activation induced deaminase (AID) gene Aicda ( Figure 2B ). The three enhancers previously shown to regulate AID transcription in vivo were also linked by PolII long-range interactions in the analysis (E3-E5, Figure 2B ; Crouch et al., 2007; Huong et al., 2013; Sayegh et al., 2003) . The Apobec1 promoter and a sixth enhancer located in Apobec1 intron 2 were also clustered ( Figure 2B ). To validate ChIA-PET associations, we deleted E1 and E2 in CH12 mouse lymphoma cells. We chose this B cell line because upon activation it transcribes high levels of AID and undergoes efficient Igm-Iga recombination (Nakamura et al., 1996) . To facilitate homozygous gene targeting, knockout constructs were cotransfected with enhancer-specific transcription activator-like effector nucleases (TALENs), assembled via a solid-phase high-throughput system (Reyon et al., 2012 ; Figure S4A ). Upon activation, wild-type CH12 cells increased AID mRNA expression $5-fold and recombined to IgA (15%, Figures 2C and 2D ). Deletion of E1 or E2 however markedly reduced AID transcription and IgA expression (Figures 2C and 2D) , consistent with the notion that the extent of switching is proportional to AID expression (Takizawa et al., 2008) . Transcription of Apobec1 was also impaired in the mutant cells, whereas noninteracting Ezh2 and Cd83 genes were unaffected ( Figure 2C ). Importantly, E1
À/À and E2 À/À cells displayed an overall reduction in Nipbl and PolII occupancy at all regulatory domains within the Aicda locus, including the Apobec1 promoter ( Figure 2E and S4B). In contrast, this effect was not observed at the Foxj2-Necap1 locus, $190 kb downstream of Apobec1 ( Figure 2E and S4B). Thus, E1 and E2 regulate AID and Apobec1 transcription by controlling local recruitment of PolII.
To further validate the ChIA-PET results, we targeted additional regulatory elements associated with the Pou2af1 (OCA-B), and Cd79a genes. We uncovered an intronic enhancer (E3) $15 kb downstream of OCA-B TSS required for transcriptional upregulation upon B cell activation but dispensable for basal transcription in nonstimulated cells ( Figure S4C ). This activity is consistent with the reported dynamics and signaling requirements of OCA-B expression during B cell differentiation (Casellas et al., 2002; Qin et al., 1998) . A similar analysis confirmed the presence of enhancer elements that augment basal Cd79a transcription ( Figure S4D ). Additional gene targeting experiments within the Pim1 oncogene locus are discussed below ( Figure 5 ). Taken together, these results demonstrate that at least a fraction of PolII long-range interactions, as defined by ChIA-PET, represent functional promoter-enhancer connections in B lymphocytes.
Single-and Higher-Order Gene Clusters in Primary Mouse Cells
Up to 54% of genes recruiting PolII in activated B cells were associated with long-range interactions (6,890 of 12,652). Of these, 1,231 (18%) represented single promoters tethered to at least one enhancer ( Figure 3A ). These clusters created complex architectures and spanned an average of 78 kb of genomic DNA ( Figure S5A ). The most elaborate of this group was the Gpr183 promoter, which was connected either directly or indirectly to 12 enhancers via 76 long-range interactions ( Figure 3A ). Another example was Cd83, which displayed 158 PolII intragenic and extragenic connections ( Figure 3B ).
Among single-promoter gene clusters, we found examples of the recently dubbed superenhancer domains (Whyte et al., 2013) , which were defined based on clustering of gene regulatory domains: e.g., mir290/295 and Sox2 loci (Figures S5B and S3A) . However, the vast majority of anchored genes (5,606, 81%) formed higher-order multigene complexes (1,481 B cell clusters, Figure 3C ), which could not be easily deduced as interacting based on visual inspection of DHS island distribution. The average span of these clusters was 179 kb ( Figure S5A ). Its prime example in B cells was the Rela cluster in chromosome 19, which was composed of 66 genes and 398 long-range interactions (Figure 3C) . Promoters linked by intergenic connections displayed higher PolII density and mRNA synthesis relative to genes from single-promoter clusters or not anchored to other domains (Figure S5C ). Furthermore, families of genes coexpressed during ontogeny were overrepresented in the multiple-promoter gene group (see Experimental Procedures). Among these we found the major histocompatibility complex H2-Mb cluster (Fisher exact test p = 1.3 3 10 14 ), the Hist1h histone family (p = 7.7 3 10 82 ), and the lymphoid signaling Gimap cluster (p = 7.6 3 10 14 , Figure S5D ).
In contrast to promoters, which readily formed higher-order complexes, the vast majority of enhancers ($90%) were linked to a single promoter, and less than 2% of all enhancers were linked to more than two promoters (Table S1 ). One exception was an enhancer downstream of Gimap6, which was directly linked to seven promoters ( Figure S5D ).
Transcriptional Correlation between lncRNA and Associated Coding Genes Long noncoding RNAs (lncRNA) are a new class of RNAs believed to play regulatory functions (Batista and Chang, 2013) . ChIA-PET identified hundreds of associations between proteincoding and lncRNA genes in multiple-promoter clusters. For instance, lncRNA E(ENSMUSG)85930 is extensively associated with Clec2d and to a lesser extent with Cd69 ( Figure 3D ). Other examples involving genes key for B cell development included Ptprcap-E90702, Cd81-E59277, and Bcl11a-E123592 pairs ( Figure S5E ). lncRNAs are believed to modulate transcription of See also Figure S4 and Table S3. neighboring genes by promoting local topological changes in chromatin (Ponting et al., 2009) . Consequently, transcription of lncRNAs and their targeted genes is often coordinated (Guil and Esteller, 2012) . To test this idea across the genome we measured expression of lncRNAs and their interacting proteincoding genes as defined by ChIA-PET. We found that genes associated with highly abundant lncRNAs were transcribed at higher levels than those associated with lncRNAs detected at low or trace levels (p < 0.05, Figure 3E ). These findings are consistent with the proposal that transcription of lincRNAs and their targets can be coordinated. Whether the same scenario applies to promoter-promoter clusters not involving lncRNA remains to be determined.
Broadly Expressed Genes Are Linked to Cell-TypeSpecific Enhancers As expected, genes differentially expressed in B and ES cells were linked to tissue-specific regulatory elements. The pluripo- 
Clec2d
Cd69 E85930 E2(13) E3 (2) E4 ( tent gene Sox2 for instance was associated with ES-cell-specific enhancers ( Figure S3A) . Conversely, the B-cell-specific Cd79b gene was only anchored to enhancers in the B cell compartment ( Figure S6A ).
We next turned our attention to genes transcribed in both cell types. Of 6,890 promoters anchored by ChIA-PET in B cells, 4,854 (70%) were also anchored in ES cells ( Figure 4A , Venn diagram). As an example, the Hexim1-2 genes were linked to the same downstream enhancer (E1) in B and ES cells ( Figure 4B ). Surprisingly, most anchored promoters in the two cell types (4,430, 94%) were associated with at least one additional tissuespecific enhancer ( Figure 4A , lower pie chart). A striking example was the Myc proto-oncogene, which displayed a completely different enhancer landscape in ES and B cells ( Figure 4C) . In B cells, Myc was linked to ten enhancers (E5-E14) located near or downstream of exon 3 of the lncRNA Pvt1, whereas in ES cells all enhancers associated with Myc (E1-E4) were found upstream of this site ( Figure 4C ). Other examples included Tgif1, Smad7, and Malat1, which were preferentially linked to ES-cell-specific enhancers, whereas Swap70, Etv5, and Pim1 were tethered to a greater number of enhancers in B lymphocytes ( Figure 4D ).
To explore whether changes in the enhancer landscape impacts transcription of this gene group, we measured their expression by calculating mRNA copy numbers per cell. Genes that turned on or off a single tissue-specific enhancer displayed little or no changes in transcription levels in the two cell types ( Figure 4E) . However, as genes interacted with two or more additional enhancers their expression was significantly different (p < 9 3 10 10 , Figure 4E ). Myc, for instance, was transcribed $4 times higher in B cells than in ES cells (Table S2 ). This observation is consistent with the notion that, in general, transcription levels of a given promoter are commensurate with the number of regulatory domains it is regulated by . On the basis of these findings we conclude that (1) broadly expressed genes can be regulated by cell-type-specific enhancers and (2) the turning on and off of enhancers during ontogeny impacts transcription levels.
Dynamic CpG Methylation of Cell-Type-Specific Regulatory Domains Cellular differentiation is accompanied by changes in DNA methylation at promoters and distal regulatory domains (Shen et al., 2013; Song et al., 2013; Stadler et al., 2011; Ziller et al., 2013) . To explore whether the dynamics of DNA methylation correlate with differential enhancer usage, we applied bisulphite sequencing (Bis-Seq) and generated methylome libraries at single-nucleotide resolution. Bis-Seq of activated B cells provided a total of 148 billion mappable methylome bases. We complemented this data set with Bis-Seq libraries from mouse ES cells (Stadler et al., 2011) and calculated the percentage of CpG methylation at gene regulatory domains. With few exceptions, activated B-cell-specific enhancers were highly methylated in ES cells (>80% of CpGs), whereas enhancers common to both cell types displayed a broad range of CpG methylation levels ( Figure 5A ). High methylation was also observed at ES cell-specific enhancers in activated lymphocytes, whereas B cell enhancers displayed low methylation levels ( Figure 5A) . Importantly, the level of CpG methylation was lower at active than at poised enhancers (p < 3 3 10 16 , Figure 5A ). As expected, promoters of silent genes displayed on average higher CpG methylation than active ones (p < 2.2 3 10 16 , Figure 5A ). Methylation levels were also inversely proportional to the extent of ChIA-PET signals ( Figure S6B ). Thus, enhancers are highly methylated when inactive, but become demethylated during development concomitant with the presence of tissue-specific PolII interactions. We explore in Figure 5B transcriptional regulation of the Pim1 oncogene, whose promoter is tethered to an entirely different set of enhancers in activated B cells and ES cells. The analysis shows a direct correlation between CpG demethylation and enhancer usage. For instance, B cell enhancers E2 and E5 and ES cell enhancers E6 and E7 display nearly complete CpG demethylation in a cell-type-specific manner ( Figure 5B ). To confirm that these enhancers truly promote Pim1 transcription, we targeted E2 and E6 in CH12 B cells and ES cells, respectively. As measured by qPCR, we found a significant decrease in Pim1 mRNA levels in the targeted cells, whereas expression of Brd2, Mtch1, and Gapdh was unaffected ( Figure 5C ). Attempts to delete E2 and E6 in the cell type where they are inactive were unsuccessful (not shown), likely due to the inability of TALENs to target methylated DNA (Bultmann et al., 2012) .
In ES cells, B-cell-specific enhancers, including those linked to broadly expressed genes, were hypermethylated ( Figure S6C) . To examine at which stage during B lymphopoiesis these regulatory elements become demethylated, we generated methylome libraries from bone marrow hematopoietic stem cells (KSL), B lymphoid precursors (CLP), and peripheral G 0 resting B cells. Of 1,518 B-cell-specific enhancers that were linked by long-range interactions and hypomethylated during activation, only 82 (5%) were also hypomethylated in ES cells ( Figure 5D ). However, in KSL precursors nearly half (714, 47%) of activated B cell enhancers were already demethylated ( Figure 5D ). This group included Pim1 enhancers E2, E3, and E5, which displayed nearly identical CpG methylation levels in KSL, CLP, G 0 resting, and cycling B cells ( Figure S6D ). As KSLs develop into CLP B cell precursors, demethylation was observed in 61% (926) of B cell enhancers. In resting G 0 B cells, this number increased to 80% (1,207, Figure 5D ). At this stage of development, the overall mean methylation was comparable between activated B cell enhancers and those functional both in B and ES cells (Figure S6C) . Thus, most activated B cell enhancers, including those associated with broadly expressed genes, are demethylated by the time naive lymphocytes migrate from the bone marrow to the periphery. This finding is consistent with the notion that the genome of G 0 lymphocytes is primed for activation and that most genes expressed during the humoral immune response are transcribed at basal levels in the naive compartment (Kouzine et al., 2013; Nie et al., 2012) . At the same time, it is important to point out that $20% of activated B cell enhancers do not become fully demethylated until activation occurs. Among these, we find Pim1 E4 and Aicda E3 and E4 ( Figures S6D and S6E ).
Digital Genomic Footprinting Characterizes TF Binding in the Mouse Genome
The observation that cell-type-specific enhancers can promote transcription of broadly expressed genes implies that factors driving lineage specification are involved in this regulation. To explore this idea, we sought to comprehensively catalog transcription factor occupancy in mouse B lymphocytes and ES cells. To this end, we took advantage of the fact that transcription factors protect their binding sites from DNaseI cleavage, leaving nucleotide-resolution footprints within DHS islands (Neph et al., 2012) . Figure 6A , for instance, shows four DNaseI footprints at the Pold4 gene promoter in G 0 and cycling B cells. Importantly, these footprints overlap with recognizable binding motifs for transcription factors PU.1, Ebf1, Egr1, and Sp1 ( Figure 6A ). By applying an established algorithm (Baek et al., 2012) , we detected 706,669 high-confidence (FDR < 5%) footprints within 75,917 B cell DHS domains (70% of total DHS). To link these footprints to known transcription factor recognition sequences, we examined all empirically defined DNA binding motifs, compiled by HOMER, UniPROBE, JASPAR, and similar databases. We found a significant enrichment in transcription factor binding motifs within DHS footprints (p < 1 3 10 6 , Figure S7A ).
Altogether, we linked 247 distinct transcription factor DNA motifs to 122,505 footprints in B cells (Table S1 ). In addition, de novo motif discovery yielded 18 new binding sites that did not match known recognition sequences (Table S1) . A similar analysis linked 306 DNA motifs to 346,284 footprints in ES cells (Table S1 ). Figure 6B shows examples of cleavage profiles for transcription factors Irf8, Sp1, Nrf1, PU.1, and CTCF (an extended view of footprints is provided in Figure S7B ). Importantly, ChIPseq analysis showed a correlation between PU.1 and CTCF occupancy, their DNA binding motifs, and cognate footprints (legend continued on next page) ( Figure 6C ). Similar results were obtained with Irf8 and Ebf1 (not shown). To confirm that footprinting profiles truly reflect the morphology of DNA-protein interactions, we turned to available transcription factor:DNA cocrystal structures. For instance, consistent with the published Ebf1:DNA structure (Treiber et al., 2010) , backbone phosphates in direct contact with Ebf1 amino acids via hydrogen bounds (in red in Figure 6D ) were the most protected from DNaseI cleavage, whereas more exposed residues (in cyan) displayed by comparison greater susceptibility to digestion. Similarly, for the cRel (NF-kB) factor DNaseI (D) Genes classified by the total number of tissue-specific enhancers they interact with. Individual examples are highlighted and the number of B-cell-specific (red) and ES-cell-specific (blue) enhancers is provided in parenthesis.
(E) Box plot providing changes in mRNA copy number for genes that are anchored both in B and ES cells and that associate with %2 ES-cell-specific enhancers (blue), R2 B-cell-specific enhancers (red), or genes in between (gray). See also Figure S6 and Table S2 . cleavage paralleled the topology of the protein-DNA interphase with a marked depression at DNA binding motif (Figure 6E ; Huang et al., 2001) . We conclude that DNaseI cleavage profiles can recapitulate the structural features of transcription factor:DNA interactions, and thus they reflect the occupancy of gene regulatory proteins across the genome.
Lineage-Determining Factors Regulate Transcription of Broadly Expressed Genes
Having validated the genomic footprinting approach, we next turned to the question of whether lineage-specific factors associate with enhancers controlling transcription of broadly expressed genes.
To this end we classified B and ES cells enhancers into three groups: (1) those shared between the two cell types and linked to the same promoter as determined by ChIA-PET, (2) cell-type-specific enhancers bound to promoters active both in B and ES cells, and (3) cell-typespecific enhancers linked to cell-type-specific promoters (Figure 7A) . Within the B cell compartment, all transcription factors analyzed were associated with the three enhancer groups. Ebf1, Oct2, and E2A footprints for instance showed no significant differences in their distribution regardless of enhancer specificity ( Figure 7B ). Other factors, such as E2f2 and Foxo1 displayed statistical significant biases for shared and cell-typespecific enhancers, respectively ( Figure 7B ). However, even in these cases, footprints were not excluded from any enhancer group. A similar distribution was observed in ES cells (Figure S7C) . Thus, lineage specification factors associate both with tissue-specific and broadly active enhancers. Confirming this finding, ChIP-seq analysis of the pluripotent factors Nanog, Oct4, and Sox2 showed occupancy of B and ES cell shared enhancers at the Ube2g1 locus as well as binding to ES-cell-specific enhancers at the Myc locus ( Figure 7C) . A global analysis of Irf4, Irf8, Pu.1, Ebf1, and Stat6 ChIP-seq from B cells also corroborated the results (data not shown). We conclude that transcription factors driving lineage specification associate with regulatory elements of broadly expressed genes. We point out that the functional significance of TF recruitment as defined by digital footprinting remains to be empirically determined. At the same time, our findings are consistent with the notion that broadly expressed genes can be regulated in a tissue-specific manner.
DISCUSSION
We have here characterized the first interactomes of gene regulatory domains in primary cells. The data provide a wealth of information from the mouse genome with thousands of promoter-enhancer pairs. Even for loci that have been extensively studied, the analysis uncovered new connectivities. At the Igk locus, for instance, we identified novel enhancers linked to 5 0 Ek, the regulatory domain from which NF-kB was originally isolated 27 years ago (Sen and Baltimore, 1986) . ChIA-PET also uncovered three additional enhancers tethered at a long distance (up to 50 kb) to the AID gene promoter; the previously characterized AID enhancers are all located within 15 kb of the TSS. Thus, one clear advantage of ChIA-PET lies in its ability to identify longrange interactions, even when they leapfrog noninteracting genes, as is the case for 65% of all enhancers (Table S1) . A striking example is a pair of giant enhancers linked to Pax5 by skipping over $250 kb of DNA containing the Zcchc7 gene ( Figure S7D ).
Like other conformation capturing techniques, ChIA-PET does not directly address functionality of chromatin interactions. This can only be determined empirically by other means. Typically, enhancer activity is defined by luciferase-based plasmids or LacZ transgenes. However, these experimental approaches only provide an incomplete view of transcriptional regulation because they either lack proper chromatin structure or the influence of neighboring enhancers, insulators, and silencers is not taken into account. Conversely, genome editing provides a means to measure the impact of enhancer deletion in the physiological context. In most cases, we found that cognate promoter activity was partially reduced following enhancer ablation, supporting the model that the contribution of individual enhancers to gene expression is additive in nature. Examples of this category were enhancers linked to the Cd79a, Pou2af1, and Pim1. On the other hand, the targeting of AID 5 0 enhancers E1 or E2 nearly entirely abolished AID expression and activity, a result that is reminiscent of those obtained upon deletion of AID enhancers E3 and E5 in BAC transgenic mice (Crouch et al., 2007; Huong et al., 2013) , or by interference with E4 activity in primary B cells (Sayegh et al., 2003) . Thus, rather than working in additive fashion, AID gene regulatory elements seem to synergize or act as a cooperative unit. Conceivably, the local topology of the Aicda-Apobec1 locus requires activation of all enhancers for optimal transcription to occur. This strategy may be useful for genes that require tight regulation as AID, whose expression is strictly limited to activated B cells to minimize its well known tumorigenic activity (Casellas et al., 2009) . Consistent with this model, our methylome analysis indicates that the AID locus is not completely demethylated until B cells are activated.
A direct comparison between the B and ES cell interactomes revealed that up to 95% of genes anchored in both cell types are associated with at least one tissue-specific enhancer. Transcription modularity, the mechanism whereby genes accumulate regulatory elements during ontogeny, is a well-described phenomenon that controls the spatiotemporal expression of developmental genes (Davidson, 2001; Visel et al., 2007) . For instance, the cardiac homeobox gene Nkx2-5 is targeted to specific subregions of the developing heart by turning on additional cis-regulatory domains over time (Schwartz and Olson, 1999) . Similarly, expression of the human apolipoprotein E gene is triggered in hepatocytes and astrocytes by enhancers only active in those tissues (Grehan et al., 2001 ). Our studies demonstrate that the turning on and off of enhancers is not a singularity of developmental gene loci. Instead, it is a widespread mechanism that regulates broadly expressed genes involved in basic cellular functions, such as cell-cycle initiation (Myc), signal transduction (b-catenin), and cellular motility (Malat1).
Mechanistically, we show that the changing enhancer landscape in mammalian development results from the unbiased recruitment of lineage-determining factors, which associate with enhancers anchored not only to tissue-specific promoters but also to constitutively active ones. Based on these observations we propose a ''relay race'' model of transcriptional regulation, whereby broadly active genes make use of tissue-specific cis-regulatory elements and transcription factors as cells progress through development ( Figure 7D ). For genes that only replace a subset of their regulatory domains, transcription is roughly maintained at comparable levels in different cell types. However, as the number of connected enhancers fluctuates considerably, promoter activity can be significantly altered.
We can think of at least two reasons why higher organisms modulate the enhancer landscape of broadly expressed genes. First, as aforementioned, it enables fine-tuning of protein output, which in turns controls protein activity. Second, it places basic cellular functions under the control of tissue-specific factors. In the B cell compartment, these strategies are perhaps best illustrated during the immune response to invading pathogens. In this microenvironment B lymphocytes move rapidly from a G 0 , quiescent state to one of the fastest proliferative rates among eukaryotic cells (Liu et al., 1991) . Key in this process is Myc which, along with TFIIH, triggers a $10-fold amplification of the lymphocyte transcriptome concomitant with cell-cycle entry (Kouzine et al., 2013; Nie et al., 2012) . Thus, vis-à -vis proliferation B cells differ substantially from continuously dividing ES cells, in that they must rapidly engage a burst of Myc expression and activity during the immune response to cope with fast dividing pathogens. Our studies imply that this unique response is mediated, at least in part, by the large number of cis-and trans-responsive elements that associate with the Myc promoter in the B cell compartment.
EXPERIMENTAL PROCEDURES
Cell Isolation and Culture Hematopoietic stem cells were isolated from the bone marrow of 25 6-weekold C57BL6 mice (Jackson Laboratory). Cells were purified following Ema et al. 's protocol (PMID: 17406558) . KSL (KIT+, SCA1+, Lin-, IL-7R-) and CLP (KIT+, SCA1+, Lin-, IL-7R+) cells were sorted using MoFlo Legacy (Beckman Coulter) and BD FACSAria III. Resting splenic B cells were isolated from 6-to 8-week-old wild-type C57BL6/J mice with anti-CD43 Microbeads (antiLy48; Miltenyi Biotech) and were activated for 48-60 hr with LPS (50 mg/ml; Sigma), IL-4 (5 ng/ml; Sigma) and 0.5 mg/ml of anti-CD180 (RP105) antibody (RP/14, BD PharMingen). E14 tg2A mouse embryonic stem cells were maintained as described in (PMID:18555785). Switchable IgM + /IgA + murine CH12-F3 Ly-1 + B cell lymphoma line was maintained and passaged every 2 days in RPMI 1640 supplemented with 10% FBS (ATCC), 1% penicillin/ streptomycin (Invitrogen), 55 mM 2-b mercaptoethanol (Invitrogen). All cells were maintained at 37 C and 5% CO 2 in a humidified incubator.
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